Last reviewed · How we verify

NCT07328412

Aromatherapy to Address Psychological Distress in Emergency Department Patients.

Not yet recruiting NA Last updated 9 January 2026
What this trial tests

NA trial testing Lavender Aromatherapy in Aromatherapy in 60 participants. Not yet recruiting.

Timeline
30 January 2026
Primary endpoint
30 March 2026
30 March 2026

Quick facts

Lead sponsorBrigham and Women's Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment60
Start date30 January 2026
Primary completion30 March 2026
Estimated completion30 March 2026

Drugs / interventions tested

Conditions studied

Sponsor

Brigham and Women's Hospital

Who can join

18 and older, any sex, with Aromatherapy or Anxiety. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to understand the feasibility and acceptability of a brief aromatherapy session for reducing stress, anxiety, and improving patient satisfaction among emergency department patients. The main question the study aims to answer is: Is the intervention acceptable and feasible? Participants in the intervention group will receive a lavender-scented tube and smell it for about 5 minutes. Participants in the control group will receive an unscented tube and follow the same instructions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Lavender Aromatherapy

Trials testing the same drug.

Other recruiting trials for Aromatherapy

Currently open trials in the same condition.

Other Brigham and Women's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07328412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing